*The assessment made available on the Vionti Health website does not create a doctor-patient relationship between the individual completing the assessment and Vionti Health. Our network of US-licensed doctors adheres to rigorous medical protocols designed for patient safety and has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Vionti Health assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and a licensed clinician will meet with an individual after checkout to determine if they qualify for a prescription. Licensed clinicians retain the decision to prescribe compounded GLP-1s to patients.
Potential benefits and outcomes described on this website are based on published clinical information about GLP-1 medications. Individual results vary based on factors including medication, starting weight, treatment duration, adherence, diet, and physical activity. Compounded GLP-1s are produced in regulated facilities but are not FDA-approved or evaluated by the FDA for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, informed by a telehealth consultation and medical history.
We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Vionti Health does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.
Results vary based on medication, starting weight, treatment duration, program adherence, diet, physical activity, and other individual factors. Any weight-loss figures on this website summarize published clinical research and do not guarantee individual outcomes. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. Consult a healthcare professional before using medication or starting any weight-loss program.
Medication is included in the cost of the Vionti Health Program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss. The trademarks, service marks, trade names (Wegovy®, Ozempic®), and products displayed on this Internet site are protected and belong to their respective owners. Medical treatment is provided by affiliated networks for medical professional corporations and associations. Clinical data and outcome ranges presented on this website are drawn from published research and do not guarantee individual outcomes.
